The first instance of undoubted sarconia induction at the site of the injection of lard in fowls cited above was complicated by the fact that the same birds had been injected with a solution of 1:2:5:6-dibenzanthracene in lard in the right breast and with lard alone in the left breast. Tumours developed in the right breast only in 7 of these birds, and in both breasts in 3 others. The lard had been heated to 140' C. during the preparation of the material, and cooled to 40' before injectioii. The following comment is quoted from the above reference : " The possibility that heated lard alone may have determined the occurrence. of tumours in a susceptible bird cannot be excluded. . . . Incidentally these experiments suggest that the quantity of dibenzanthracene actually required to initiate sarcomatous growth must be remarkably small, since the bulk of the the injection appears to remain encapsulated throughout the expei-inient " (Peacock, 1933) . The latter assumption subsequently proved to be wrong. To test this point, Chalmers (1934) analysed the contents of encapsulated niatter from the site of dibenzanthracene lard injection in one of Peacock's sarcoiiia-bearing fowls, which died 7 months after the last injectioii. The method of spectrographic analysis en-iployed was capable of detectiiig 0-01 mg. of dibenzaiitlii-acene in an exti-act of fowl inuscle, but failed to detect dibenzaiithracene in the extract of encapsulated debris from this bird.
Furtlier tests oii birds in the same experiment confiriiied the abseiice of demonstrable dibenzanthracene 6 months or more after injection. In order to avoid the use of foreign fats, chicken fat and egg yolk fat were used as vehicles for the injection of dibenzanthracene into fowls. It was found that when either of these solvents was used as vehicle dibenzanthracene rapidly disappeared from the site of injection, and was undetectable after 3 weeks. In paraRel experiments (Peacock, 1935 (Peacock, , 1936a Thirty-six mice of mixed stock were each injected subcutaneously in the right flank with 0-3 ml. of a 0-I per cent solution of benzpyrene in tricaprylin ; 3:4-benzpyrene was supplied by Ward, Blenkinsop & Co., Ltd., London, and tricaprylin by British Drug Houses, Ltd. The mice were killed after different periods (Table 1) , the subcutaneous tissues exposed and examined for ultra-violet fluorescence. Sixteen of 20 mice killed at various times over a period of 7 months had fluorescent material located at the original site of injection ; ulceration and sepsis at the site of injection killed 4 mice early in the experiment. In 3 of these mice no sign of the injected material was found, probably due to sloughing and leakage from the site of injection. The fourth had a small spot of fluorescence. These mice were not examined further ; in the remainder the fluorescent material was extracted with benzene, with the exception of 2 mice, which died after 412 -and 51 months, both showing persistent fluorescence and tumours at the site of injection.
After the third month of experiinent tumours began to be clinically recognized at the sites of injection. The fluoresmnee spectra were recorded with a Hilger Medium Quartz Spectrograph, using Ilford Iso-Zenith Plates. A smaR gLus cell of 0-5 ml. capacity held the solution for test close to the slit of the spectrograph, and the fluorescence was excited by radiation from a G.E.C. Osira-lamp focused on t-o the cell by a condensing lens. The slit width used throughout was 0-I mni. and trhe exposures varied from 1-60 minutes, depending on the fluorescence intensity of the solution.
RESULTS.
T& n-ature of the fluore-went m-aterial at the site of inj'eclion.
The relative intensities ofthe characteristic bands of the fluorescence spectrum of benzpy-rene in pure benzene (Fig. 1, Spectrum (a) (4) Extracts 7 month-s after injection.-Fluorescent niaterial was extracted froi-n 2 mice, both bearing tumours, one large and one small. The extract frojii the mouse with the large tumour gave a spectrum similar to that shown in Spectrum (i) after 60 minutes' exposure. There was no evidence of the presence of benzpyrene. The fluorescence spectruni of'the extract from the mouse witli the sniall tumour showed neither benzpyrene nor a known metabolite, but gave inerely a continuous spectrum. Table I shows the relationship which exists between the tumour incidence aiid the persistence of benzpyrene at the site of injection. It may be noted that the W iiiiee which sur-\.-ived lonaest lia(l no titinotirs an(I iio persistent fltioresceiiee, ,tt, the site of ii-jectioii. SIUMMARY.
